又退市?!飞利浦又一重要产品召回后彻底退出市场

医疗器械创新网
04 Mar

2025年3月,飞利浦医疗宣布对旗下外周血管介入产品Tack Endovascular System(PTA术后修复支架)启动一级召回并永久退市。此次召回涉及多批次产品,原因系操作风险导致血管损伤等严重健康威胁,已报告20例伤害病例。FDA警告称,继续使用该设备可能导致截肢甚至死亡。01被“退回”的Tack支架涉及产品:Tack Endovascular System (4F,1.5-4.5mm)...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10